1 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
2 Runge VM.Safety of the gadolinium-based contrast agents for magnetic resonance imaging,focusing in part on their accumulation in the brain and especially the dentate nucleus[J].Invest Radiol,2016,51(5):273-279.
3 Guo C,Ling S,Hao C,et al.Gadolinium-labeled biodegradable dendron-hyaluronic acid hybrid and its subsequent application as a safe and efficient magnetic resonance imaging contrast agent[J].Acs Appl Mater Interfaces,2017,9(28):23508-23519.
4 Nntn N,Tinet E,Ettori D,et al.Gadolinium/terbium hybrid macromolecular complexes for bimodal imaging of atherothrombosis[J].J Biomed Opt,2017,22(7):76004.
5 Besemer AE,Titz B,Grudzinski JJ,et al.Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404[J].Phys Med Biol,2017,62(15):6008-6025.
6 辛小燕,刘宝瑞,朱斌.肿瘤主动靶向性钆类磁共振分子影像探针的研究进展[J].医学影像学杂志,2013,23(11):1781-1783.
7 李益婷,徐杨,蔡镇西,等.整合素αⅡβ3信号转导通路相关蛋白的研究进展[J].上海交通大学学报(医学版),2013,33(9):1311-1314.
8 Zhou Z,Han Z,Lu ZR.A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging[J].Biomaterials,2016,85:168-179.
9 Park JA,Lee YJ,Ko IO,et al.Improved tumor-targeting MRI contrast agents:Gd(DOTA)conjugates of a cycloalkane-based RGD peptide[J].Biochem Biophys Res Commun,2014,455(3/4):246-250.
10 Goswam LN,Ma L,Cai Q,et al.cRGD peptide-conjugated Icosahedral closo-B122-core carrying multiple Gd3+-DOTA chelates for αvβ3 integrin-targeted tumor imaging(MRI)[J].Inorg Chem,2013,52(4):1701-1709.
11 Katzenellenbogen R.Telomerase induction in HPV infection and oncogenesis:[J].Viruses,2017,9(7):180.
12 朱高红,任炳秀,卫江亮,等.Gd-DOTA-hTERT ASON磁共振肿瘤端粒酶靶向显像实验研究[J].中国癌症杂志,2013,23(10):821-828.
13 林红,牛膺筠,周占宇,等.眼睑恶性肿瘤组织中基底膜蛋白的分布和表达及临床意义[J].中华眼科杂志,2003,39(3):167-171.
14 Wu X,Yu G,Lindner D,et al.Peptide targeted high-resolution molecular imaging of prostate cancer with MRI[J].Am J Nucl Med Mol Imaging,2014,4(6):525-536.
15 Zhou Z,Qutaish M,Han Z,et al.MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent[J].Nat Commun,2015,6:7984.
16 Zhou Z,Wu X,Kresak A,et al.Peptide targeted tripod macrocyclic Gd(III)chelates for cancer molecular MRI[J].Biomaterials,2013,34(31):7683-7693.
17 Takahashi S.Vascular endothelial growth factor(VEGF),VEGF receptors and their inhibitors for antiangiogenic tumor therapy[J].Biol Pharm Bull,2011,34(12):1785-1788.
18 Jun HY,Yin HH,Kim SH,et al.Visualization of tumor angiogenesis using MR imaging contrast agent Gd-DTPA-anti-VEGF receptor 2 antibody conjugate in a mouse tumor model[J].Korean J Radiol,2010,11(4):449-456.
19 Kuo Y C,Hung C,Gullapalli R,et al.Liposomal nanoprobes that combine anti-EGFR antibodies and MRI contrast agents:synthesis and in vitro characterization[J].Rsc Advances,2014,4(64):33756-33764.
20 陈凯云,常佳丽,陈卫东.叶酸纳米给药系统抗肿瘤作用研究进展[J].中南药学,2017,15(5):626-630.
21 Yuan Z,Li WT,Ye XD,et al.Folate receptor-mediated targeted polymeric gadolinium complexes for magnetic resonance imaging in pulmonary tumor xenografts[J].Exp Ther Med,2012,3(5):903-907.
22 Du H,Shen Y,Liu Y,et al.Dextran gadolinium complex containing folate groups as a potential magnetic resonance imaging contrast agent[J].Chinese J Polym Sci,2015,33(9):1325-1333.
23 Nan D,Yao L,Lee RJ,et al.Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging[J].Int J Nanomedicine,2011,6:2513-2520.
24 Adi P,Hadassa D.Estrogen receptor-targeted contrast agents for molecular magnetic resonance imaging of breast cancer hormonal status[J].Front Oncol,2016,6:100.
25 孙艳,郭小超,黄勇,等.MR钆对比剂全身性不良反应的研究:18540例连续病例分析[J].放射学实践,2016,31(12):1159-1162.
26 陈仲良,江治民,刘洁,等.钆对比剂在动态增强磁共振成像中的应用[J].分子影像学杂志,2016,39(3):342-344. |
